Moody's Corporation vs 10X Genomics Inc — how do they compare? Moody's Corporation trades at $490.77 (market cap $88.28B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Moody's Corporation is far larger — about 16.1× 10X Genomics Inc's market cap, and Moody's Corporation pays a 0.82% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| MCO | TXG | |
|---|---|---|
Market Cap | $88.28B | $5.48B |
Sector | Financials | Health |
52-Week High | $539.61 | $45.80 |
52-Week Low | $412.23 | $11.34 |
Enterprise Value | $94.08B | $5.02B |
Dividend Yield | 0.82% | — |
Trailing returns across standard periods
Latest headlines on both assets
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.
Read more on MCO →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →